Epinephrine nasal spray favored over autoinjectors by patients, health care professionals

Health care professionals and adults at risk for severe anaphylaxis both reported inconsistent patient epinephrine autoinjector adherence, according to survey data. These findings, presented at the 2026 European Academy of Allergy and Clinical Immunology Annual Congress, also show that epinephrine nasal spray (EURneffy, ARS Pharmaceuticals) was favored/preferred over autoinjectors in both